SciELO - Scientific Electronic Library Online

vol.62 issue5Prostatic specific antigen (PSA), pro-inflammatory cytokines, and prostatic pathology (Benign prostatic hyperplasia and cancer): Relationship with malignancyThird generation sub-mid urethral mesh: Experience with 110 TVT-Secur author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Archivos Españoles de Urología (Ed. impresa)

Print version ISSN 0004-0614


VIDAL MORA, Ivar et al. Upper urinary tract transitional cell carcinoma: Current treatment options and minimally invasive approaches. Arch. Esp. Urol. [online]. 2009, vol.62, n.5, pp.367-375. ISSN 0004-0614.

Objectives: Upper urinary tract transitional cell carcinoma (UUT-TCC) is a rare disease. Open nephroure-terectomy remains the gold standard for surgical treat-ment. We aim to evaluate the standing of novel surgical treatment in UUT-TCC. Methods: Extensive review of available literature on UUT-TCC, with emphasis in surgical treatment. English medical literature available in PubMed, Ovid, EMBASE y Science Direct was employed for the study. Resultados: Laparoscopic nephroureterectomy, ureteroscopy and percutaneous treatment are the available surgical options that based on adequate patient selection offer acceptable cancer control. Conclusiones: Indications for the treatment of UT-TCC are expanding and this allows clinicians to tailor treatment while preserving oncological results.

Keywords : Transitional cell carcinoma; Nephroureterectomy; Percutaneous treatment; Ureteroscopy.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License